All of these data indicate the complexity of targeting glutamine metabolism to regulate the immune response because these strategies may simultaneously cause tumor immune escape via upregulation of the expression of PD-L1 in tumors and inhibition of tumor immune escape by enhancing the function of T cells (Figure 1). Here, CD274 is linked to neoplasm.